STOCK TITAN

Leverage Shares 2X Long CAT Daily ETF (CATG) Financials

CATG
FY2025 annual
Revenue $2.6M -12.1% YoY
Net Income -$8.0M +8.2% YoY
EPS (Diluted) -$3.16 YoY not available
Operating Cash Flow -$2.6M +44.1% YoY
Market Cap $1.1M as of Sep 25, 2026
Price / Sales 0.4x on $2.6M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book n/m negative shareholder equity, so no book multiple, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 25, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Aug 31, 2025 Reported Currency USD FYE August

Newest figures come from the 10-K for FY2025, filed May 20, 2026. Each column of the statement tables below links to the filing it was taken from.

Leverage Shares 2X Long CAT Daily ETF (CATG) reported $2.6M in revenue for fiscal year 2025, down 12.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

Leverage Shares 2X Long CAT Daily ETF does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
5/8

Leverage Shares 2X Long CAT Daily ETF passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Leverage Shares 2X Long CAT Daily ETF reported a net loss of $8.0M while operations used $2.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$108K
YoY-72.1%
QoQ-72.1%

Leverage Shares 2X Long CAT Daily ETF held $108K in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding
2M

Leverage Shares 2X Long CAT Daily ETF had 2M shares outstanding in Q4 2025.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

CATG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CATG quarterly income statement
MetricQ4'2510-KQ4'2410-KQ1'13Q4'12Q3'12Q2'12Q1'12Q4'11
RevenueN/AN/A$11.6M+11.7%$10.7M+69.8%$10.2M$11.0M+80.2%$10.4M+74.0%$6.3M+4.8%
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A$3.0M-10.7%
Gross ProfitN/AN/A$3.9M+21.9%$5.4M+65.2%$4.6M$5.2M+101.4%$3.2M+4.4%$3.3M+24.9%
SG&A ExpensesN/AN/A$481K-4.7%$1.5M+2146.7%$528K$626K+70.7%$505K+51.1%$66K+22.2%
Operating IncomeN/AN/A$3.4M+26.9%$3.9M+22.4%$4.1M$4.5M+106.5%$2.7M-1.3%$3.2M+24.9%
EBITDAN/AN/A$4.5M+19.5%N/AN/AN/A$3.8M+26.9%N/A
Interest ExpenseN/AN/A$822K-40.4%$86K$2.1M$2.1M$1.4MN/A
Net IncomeN/AN/A$2.6M+96.1%$3.9M+19.9%$2.0M$2.5M+11.4%$1.3M-51.1%$3.2M+25.0%
EPS (Basic)N/AN/A$0.09+125.0%N/A$0.07$0.08+14.3%$0.04-55.6%$0.11+10.0%
EPS (Diluted)N/AN/A$0.09+125.0%N/A$0.07$0.08+14.3%$0.04-55.6%$0.11+10.0%
Diluted Shares (Avg)N/AN/A30M+0.6%N/A30M30M+0.2%30M0.0%30M+14.9%

Not reported in any period shown, so not listed: R&D Expenses, Income Tax.

CATG Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CATG quarterly balance sheet
MetricQ4'2510-KQ4'2410-KQ1'13Q4'12Q3'12Q2'12Q1'12Q4'11
Total Assets$3.0M-25.2%$4.0M$142.9M-3.0%$164.9M+193.1%$137.6M$139.2M$147.3M+199.2%$56.3M
Current Assets$413K-66.7%$1.2M$11.8M-20.8%$34.5M+147.2%$12.1M$11.5M$14.9M+70.4%$14.0M
Cash & Equivalents$108K-72.1%$386K$9.0M0.0%$30.4M+145.4%$9.0M$6.5M+33.2%$9.0M+70.1%$12.4M+5.7%
InventoryN/AN/AN/AN/A$72K$58K$37K-66.6%$79K
Accounts Receivable$210K-0.5%$211KN/AN/AN/AN/AN/AN/A
Goodwill$349K0.0%$349KN/AN/AN/AN/AN/AN/A
Total Liabilities$17.0M-38.3%$27.5M$87.1M-16.3%$112.2M+537.3%$89.6M$92.9M$104.0M+493.4%$17.6M
Current Liabilities$4.2M-82.3%$23.5M$61.7M-19.4%$86.4M+390.5%$64.4M$68.4M$76.6M+337.0%$17.6M
Non-Current Liabilities$12.8M+221.8%$4.0M$25.3M-7.5%$25.9M$25.2M$24.5M$27.4M$0
Long-Term DebtN/AN/A$11.2M$11.0MN/AN/AN/AN/A
Total Equity-$14.0M+40.5%-$23.5M$55.8M+28.8%$52.6M+36.2%$48.0M$46.3M$43.3M+36.6%$38.6M
Retained Earnings-$32.0M-35.9%-$23.5M$52.4M+28.5%$49.7M+35.6%$45.2M$43.2M$40.8M+32.9%$36.7M

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.

CATG Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CATG quarterly cash flow statement
MetricQ4'2510-KQ4'2410-KQ1'13Q4'12Q3'12Q2'12Q1'12Q4'11
Operating Cash FlowN/AN/A-$4.5M-94.9%$27.6M+1456.6%$2.5M-$1.6M-1062.3%-$2.3M+12.2%-$2.0M
Depreciation & AmortizationN/AN/A$1.1M+1.7%N/AN/AN/A$1.1M+307.6%N/A
Stock-Based CompensationN/AN/A$61K+95.3%N/AN/AN/A$31KN/A
Capital ExpendituresN/AN/A$589K+39.1%$681K+2646.5%-$247K$106K-55.8%$424K+743.5%$25K
Free Cash FlowN/AN/A-$5.1M-86.3%$26.9M+1407.2%$2.3M-$1.7M-2043.9%-$2.7M-2.0%-$2.1M
Investing Cash FlowN/AN/AN/AN/A$247K-$106K+95.7%-$424K+69.0%-$803K
Financing Cash FlowN/AN/AN/AN/A-$168K-$1.0M-$3.3M-21949.4%N/A

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CATG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CATG quarterly financial ratios
MetricQ4'2510-KQ4'2410-KQ1'13Q4'12Q3'12Q2'12Q1'12Q4'11
Gross MarginN/AN/A33.4%+2.8pp50.6%-1.4pp45.4%47.1%+5.0pp30.6%-20.4pp52.0%+8.3pp
Operating MarginN/AN/A29.3%+3.5pp36.8%-14.2pp40.2%41.4%+5.3pp25.8%-19.7pp51.0%+8.2pp
Net MarginN/AN/A22.5%+9.7pp36.1%-15.0pp19.7%22.4%-13.8pp12.8%-32.8pp51.1%+8.2pp
Return on EquityN/AN/A4.7%+1.6pp7.3%-1.0pp4.2%5.3%3.1%-5.5pp8.3%
Return on AssetsN/AN/A1.8%+0.9pp2.3%-3.4pp1.5%1.8%0.9%-4.7pp5.7%
Current Ratio0.100.0x0.050.190.0x0.40-0.4x0.190.170.19-0.3x0.79
Debt-to-EquityN/AN/A0.20-2.2x0.21-0.2x1.872.012.40+1.8x0.46
Asset TurnoverN/AN/A0.080.0x0.060.0x0.070.080.07-0.1x0.11
FCF MarginN/AN/A-43.7%-17.5pp252.2%22.2%-15.3%-14.0pp-26.2%+18.5pp-32.8%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.

Note: Shareholder equity is negative (-$14.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.10), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Leverage Shares 2X Long CAT Daily ETF CATG FY2025 $2.6M -$8.0M N/A $1.1M —
SEATECH VENTURES CORP SEAV FY2025 N/A -$39K N/A $4.2M —

Frequently Asked Questions

What is Leverage Shares 2X Long CAT Daily ETF's annual revenue?

Leverage Shares 2X Long CAT Daily ETF (CATG) reported $2.6M in total revenue for fiscal year 2025. This represents a -12.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Leverage Shares 2X Long CAT Daily ETF's revenue growing?

Leverage Shares 2X Long CAT Daily ETF (CATG) revenue declined by 12.1% year-over-year, from $3.0M to $2.6M in fiscal year 2025.

Is Leverage Shares 2X Long CAT Daily ETF profitable?

No, Leverage Shares 2X Long CAT Daily ETF (CATG) reported a net income of -$8.0M in fiscal year 2025.

Leverage Shares 2X Long CAT Daily ETF (CATG) reported diluted earnings per share of -$3.16 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Leverage Shares 2X Long CAT Daily ETF (CATG) had a gross margin of 54.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Leverage Shares 2X Long CAT Daily ETF (CATG) recorded an outflow of $2.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Leverage Shares 2X Long CAT Daily ETF (CATG) had $3.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Leverage Shares 2X Long CAT Daily ETF (CATG) had 2M shares outstanding as of fiscal year 2025.

Leverage Shares 2X Long CAT Daily ETF (CATG) had a current ratio of 0.10 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Leverage Shares 2X Long CAT Daily ETF (CATG) had a return on assets of -267.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Leverage Shares 2X Long CAT Daily ETF (CATG) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $1.1M as of Sep 25, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Leverage Shares 2X Long CAT Daily ETF (CATG) trades at 0.4x sales, its market capitalization divided by revenue of $2.6M revenue, FY2025. The market capitalization is $1.1M as of Sep 25, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Leverage Shares 2X Long CAT Daily ETF (CATG) has negative shareholder equity of -$14.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Leverage Shares 2X Long CAT Daily ETF (CATG) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Leverage Shares 2X Long CAT Daily ETF (CATG) reported a net loss of $8.0M while operations used $2.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top